Comparison of the Effects of Propofol and Sevoflurane on QT Interval in Pediatrics Undergoing Cochlear Implantation:

Reza Safaeian1, Valiollah Hassani1, Masood Mohseni1

  • 1Pain Research Center, Department of Anesthesiology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Insights

For children with sensorineural hearing loss undergoing cochlear implant surgery, propofol anesthesia appears safer than sevoflurane. Sevoflurane induction was linked to increased QT interval, a cardiac risk indicator, in this patient group.

Area of Science:

  • Pediatric Anesthesiology
  • Cardiology
  • Otolaryngology

Background:

  • Children with sensorineural hearing loss (SNHL) face risks of cardiac electrophysiologic abnormalities.
  • Inhalational sevoflurane anesthesia induction may prolong the QT interval in these children.

Purpose of the Study:

  • To compare the electrophysiologic effects of sevoflurane versus propofol for anesthesia induction in children with SNHL undergoing cochlear implantation.
  • To evaluate the safety of inhalational sevoflurane induction in this specific pediatric population.

Main Methods:

  • A double-blind randomized clinical trial involving 61 children (1-18 years) candidates for cochlear implantation.
  • Patients were randomized to sevoflurane (n=32) or propofol (n=29) for anesthesia induction.
  • Two 12-lead ECGs were recorded pre- and post-induction to measure QTc, Tp-e interval, and JTc.

Main Results:

  • Significant post-induction difference in QTc values observed between groups (sevoflurane: 445.0 ± 29 ms vs. propofol: 422.5 ± 40 ms, P=0.016).
  • A greater percentage of patients in the sevoflurane group showed an increased Tp-e interval (>100 ms).
  • No significant difference in long QTc (>500 ms or >60 ms increase) was found between groups post-induction.

Conclusions:

  • In children with SNHL and a pre-induction QTc not exceeding 500 ms, propofol is indicated as a safer anesthetic induction agent than sevoflurane.
  • Electrophysiological evaluations suggest careful consideration of anesthetic choice in SNHL patients undergoing cochlear implantation.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
525
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
215
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
535
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
214